Downregulation of microRNA-196a enhances the sensitivity of non-small cell lung cancer cells to cisplatin treatment.

@article{Li2016DownregulationOM,
  title={Downregulation of microRNA-196a enhances the sensitivity of non-small cell lung cancer cells to cisplatin treatment.},
  author={Qian Li and Zailiang Yang and Mingyan Chen and Ying Liu},
  journal={International journal of molecular medicine},
  year={2016},
  volume={37 4},
  pages={
          1067-74
        }
}
MicroRNAs (miRNAs or miRs) are a class of small, non-coding RNA molecules that play an important role in the pathogenesis of human diseases through the regulation of gene expression. Although miRNA-196a has been implicated in the progression of human lung cancer, its role in enhancing the sensitivity of non‑small cell lung cancer (NSCLC) cells to cisplatin has not yet been confirmed. The aim of this study was to evaluate the effects of miRNA‑196a on the sensitivity of NSCLC cells to cisplatin… 

Figures from this paper

MicroRNA-21 increases cell viability and suppresses cellular apoptosis in non-small cell lung cancer by regulating the PI3K/Akt signaling pathway
TLDR
The results of the present study demonstrated that miR-21 increased cell viability by inhibiting apoptosis, through regulation of Akt activation, and may be a novel therapeutic target for the disease.
MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas
TLDR
This review will contribute to the general understanding of miRNA-regulated biological processes in NSCLC, with special focus on the role of mi RNA in CDDP-resistance, and focuses on miRNAs deregulated by hypoxia, which is an important factor in the development of CDDP -resistance inNSCLCs.
MicroRNA-218 enhances gastric cancer cell cisplatin sensitivity by targeting survivin.
TLDR
The induction of miR-218 enhanced GC cell DDP resistance via the regulation of survivin, which may potentially benefit the clinical treatment of GC in the future.
Long Non-coding RNA DUXAP8 Regulates the Cell Proliferation and Invasion of Non-small-cell Lung Cancer
TLDR
The results imply that LncRNA DUXAP8 is a potential regulatory molecular marker in non-small-cell lung cancer.
Molecular Mechanisms of Chemoresistance Induced by Cisplatin in NSCLC Cancer Therapy
TLDR
A protein-protein interaction network that indicates highly dysregulated TP53, MDM2, and CDKN1A genes as they encode the top networking proteins that may be involved in cisplatin tolerance, these all being upregulated in cis platin-resistant cells is described.
Long non ‐ coding RNA SNHG 3 promotes the development of non ‐ small cell lung cancer via the miR ‐ 1343 ‐ 3 p / NFIX pathway
TLDR
The results suggested that the SNHG3/miR‐1343‐3p/NFIX axis may serve as a novel prognostic biomarker and therapeutic target for NScLc.
MicroRNA-137-regulated AKT serine/threonine kinase 2 inhibits tumor growth and sensitizes cisplatin in patients with non-small cell lung cancer.
TLDR
The results of the present study suggested that microRNA-137-regulated AKT2 inhibits tumor growth and sensitizes cisplatin in patients with NSCLC.
Serum miR-10a-5p and miR-196a-5p as non-invasive biomarkers in non-small cell lung cancer.
TLDR
It was found that miRNA-10a-5p and miR-196p expression levels were increased significantly in NSCLC tissues compared with non-tumor adjacent normal tissues and the combination of these two miRNAs with carcinoembryonic antigen (CEA) further increased the diagnostic value.
...
...

References

SHOWING 1-10 OF 43 REFERENCES
MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5
TLDR
It is indicated that miR-196a is significantly up-regulated in NSCLC tissues, and regulatesNSCLC cell proliferation, migration and invasion, partially via the down-regulation of HOXA5.
MicroRNA-10b overexpression promotes non-small cell lung cancer cell proliferation and invasion
TLDR
It is found that miR-10b is a tumor enhancer in NSCLC and may represent a potential therapeutic target forNSCLC intervention.
MiR-196a Is Upregulated in Gastric Cancer and Promotes Cell Proliferation by Downregulating p27kip1
TLDR
It is shown that aberrant overexpression of miR-196a and consequent downregulation of p27kip1 could contribute to gastric carcinogenesis and would be targets for gastric cancer therapies and further developed as potential prognostic factors.
MicroRNA-143 Inhibits Migration and Invasion of Human Non-Small-Cell Lung Cancer and Its Relative Mechanism
TLDR
The up-regulated miR-143 in lung cancer could significantly inhibit cell migration and invasion, and this might work through targeting CD44v3, which was newly identified by us.
Role of microRNAs in drug-resistant ovarian cancer cells.
High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells.
AIM To analyze the relevance of the microRNA miR-196a for colorectal oncogenesis. METHODS The impact of miR-196a on the restriction targets HoxA7, HoxB8, HoxC8 and HoxD8 was analyzed by reverse
MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers
TLDR
A novel mechanism of post-transcriptional regulation of ANXA1 expression is demonstrated and miR-196a is identified as a marker of esophageal cancer and suggested its oncogenic potential.
MiR-196a Promotes Pancreatic Cancer Progression by Targeting Nuclear Factor Kappa-B-Inhibitor Alpha
TLDR
It is demonstrated that miR-196a was up-regulated in human pancreatic cancer cell lines compared with immortalized pancreatic ductal epithelial cells by means of microRNAs microarray and qRT-PCR, and a novel NFKBIA target was identified, which may serve as a potential therapeutic target for pancreatic cancers.
Genetic variants of miRNA sequences and non-small cell lung cancer survival.
TLDR
A systematic survey of common pre-miRNA SNPs and their surrounding regions found that the rs11614913 SNP in hsa-mir-196a2 was associated with survival in individuals with non-small cell lung cancer, and may be a prognostic biomarker for NSCLC.
...
...